857 related articles for article (PubMed ID: 24322055)
1. Antifibrotic response of cardiac fibroblasts in hypertensive hearts through enhanced TIMP-1 expression by basic fibroblast growth factor.
Kinoshita T; Ishikawa Y; Arita M; Akishima-Fukasawa Y; Fujita K; Inomata N; Suzuki T; Namiki A; Mikami T; Ikeda T; Yamazaki J; Ishii T; Akasaka Y
Cardiovasc Pathol; 2014; 23(2):92-100. PubMed ID: 24322055
[TBL] [Abstract][Full Text] [Related]
2. Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat.
Xu X; Ding F; Pang J; Gao X; Xu RK; Hao W; Cao JM; Chen C
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(6):H703-11. PubMed ID: 22842067
[TBL] [Abstract][Full Text] [Related]
3. Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1.
Ma J; Ma SY; Ding CH
Chin J Integr Med; 2017 May; 23(5):362-369. PubMed ID: 26956464
[TBL] [Abstract][Full Text] [Related]
4. Basic fibroblast growth factor inhibits ventricular remodeling in Dahl salt-sensitive hypertensive rats.
Suzuki T; Akasaka Y; Namiki A; Ito K; Ishikawa Y; Yamazaki J; Ishii T
J Hypertens; 2008 Dec; 26(12):2436-44. PubMed ID: 19008723
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-gamma ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia.
Makino N; Sugano M; Satoh S; Oyama J; Maeda T
Cell Biochem Biophys; 2006; 44(1):65-71. PubMed ID: 16456235
[TBL] [Abstract][Full Text] [Related]
6. Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats.
Li G; Xing W; Zhang M; Geng F; Yang H; Zhang H; Zhang X; Li J; Dong L; Gao F
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H802-H813. PubMed ID: 29957017
[TBL] [Abstract][Full Text] [Related]
7. Activation of Cannabinoid Receptor Type II by AM1241 Ameliorates Myocardial Fibrosis via Nrf2-Mediated Inhibition of TGF-β1/Smad3 Pathway in Myocardial Infarction Mice.
Li X; Han D; Tian Z; Gao B; Fan M; Li C; Li X; Wang Y; Ma S; Cao F
Cell Physiol Biochem; 2016; 39(4):1521-36. PubMed ID: 27614871
[TBL] [Abstract][Full Text] [Related]
8. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
9. Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females.
Voloshenyuk TG; Gardner JD
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R683-93. PubMed ID: 20504902
[TBL] [Abstract][Full Text] [Related]
10. Effects of basic fibroblast factor (bFGF) on MMP-2, TIMP-2, and type-I collagen levels in human lung carcinoma fibroblasts.
Nakoman C; Resmi H; Ay O; Acikel U; Atabey N; Güner G
Biochimie; 2005; 87(3-4):343-51. PubMed ID: 15781321
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of tanshinone II A inhibiting myocardial remodeling by Galectin-3].
Zhang M; Cheng K; Yu L; Wu W; Wang Y; Chen Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jun; 34(6):640-645. PubMed ID: 35924522
[TBL] [Abstract][Full Text] [Related]
12. Abnormal Downregulation of Caveolin-3 Mediates the Pro-Fibrotic Action of MicroRNA-22 in a Model of Myocardial Infarction.
Zhang L; Yin H; Jiao L; Liu T; Gao Y; Shao Y; Zhang Y; Shan H; Zhang Y; Yang B
Cell Physiol Biochem; 2018; 45(4):1641-1653. PubMed ID: 29486470
[TBL] [Abstract][Full Text] [Related]
13. Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart.
Heymans S; Schroen B; Vermeersch P; Milting H; Gao F; Kassner A; Gillijns H; Herijgers P; Flameng W; Carmeliet P; Van de Werf F; Pinto YM; Janssens S
Circulation; 2005 Aug; 112(8):1136-44. PubMed ID: 16103240
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin reduces myocardial fibrosis in a rat model with post-myocardial infarction heart failure by increasing the matrix metalloproteinase-2/tissue matrix metalloproteinase inhibitor-2 ratio.
An Z; Yang G; He YQ; Dong N; Ge LL; Li SM; Zhang WQ
Chin Med J (Engl); 2013; 126(11):2149-56. PubMed ID: 23769575
[TBL] [Abstract][Full Text] [Related]
15. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
Hu YB; Li DG; Lu HM
J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
[TBL] [Abstract][Full Text] [Related]
16. Icariside II improves myocardial fibrosis in spontaneously hypertensive rats by inhibiting collagen synthesis.
Fu S; Li Y; Wu Y; Yue Y; Yang D
J Pharm Pharmacol; 2020 Feb; 72(2):227-235. PubMed ID: 31820448
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-323a-3p Promotes Pressure Overload-Induced Cardiac Fibrosis by Targeting TIMP3.
Zhang J; Lang Y; Guo L; Pei Y; Hao S; Liang Z; Su G; Shu L; Liu H; Huang C; Xu J
Cell Physiol Biochem; 2018; 50(6):2176-2187. PubMed ID: 30415251
[TBL] [Abstract][Full Text] [Related]
18. Cell therapy limits myofibroblast differentiation and structural cardiac remodeling: basic fibroblast growth factor-mediated paracrine mechanism.
Fedak PW; Bai L; Turnbull J; Ngu J; Narine K; Duff HJ
Circ Heart Fail; 2012 May; 5(3):349-56. PubMed ID: 22508775
[TBL] [Abstract][Full Text] [Related]
19. Calhex
Yuan H; Xu J; Xu X; Gao T; Wang Y; Fan Y; Hu J; Shao Y; Zhao B; Li H; Sun J; Xu C
Biol Pharm Bull; 2019 Aug; 42(8):1337-1344. PubMed ID: 31167987
[TBL] [Abstract][Full Text] [Related]
20. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by basic fibroblast growth factor and dexamethasone in periodontal ligament cells.
Hakki SS; Hakki EE; Nohutcu RM
J Periodontal Res; 2009 Dec; 44(6):794-802. PubMed ID: 19602122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
